Page 5 - லக்ஸம்பர்க் நிறுவனம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The future of Medical Research in Luxembourg Author: Lisa Burke|Update: 19.04.2021 06:40 Professor Dr Ulf Nehrbass, CEO of the Luxembourg Institute of Health, discusses new ways of thinking about disease and medical research. Ulf Nehrbass has become a relatively famous scientific face in Luxembourg due to his role as an advisor to the government on COVID-19 strategies. We touch on COVID in this conversation, but recognising a general ennui around the subject, we push on. Ulf wants to get on with the job in hand as CEO of the Luxembourg Institute of Health, LIH. Nehrbass track record saw him lead and found the Institut Pasteur Korea, where he sourced an international team to become one of the first translational drug discovery institutes. Ulf was also CEO and founder of Qurient Therapeutics, a Biotech near Seoul, IPO since in 2016. Since then he created a F

Soult ukpyolsiSouth koreaUlf nehrbassAlisa burkeLuxembourg institute of healthLuxembourg instituteInstitut pasteur koreaQurient therapeuticsFrench germanAlsace biovalleyதெற்கு கொரியாலிசா பர்க்லக்ஸம்பர்க் நிறுவனம் ஆஃப் ஆரோக்கியம்லக்ஸம்பர்க் நிறுவனம்நிறுவனம் பாஸ்டர் கொரியாபிரஞ்சு ஜெர்மன்